CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $67,090 | +31.5% | 3,607 | -10.9% | 0.00% | +200.0% |
| Q3 2022 | $51,000 | -23.9% | 4,048 | -57.4% | 0.00% | 0.0% |
| Q2 2022 | $67,000 | +63.4% | 9,508 | +91.5% | 0.00% | – |
| Q1 2022 | $41,000 | -10.9% | 4,965 | -26.6% | 0.00% | – |
| Q4 2021 | $46,000 | -9.8% | 6,762 | -29.3% | 0.00% | – |
| Q3 2021 | $51,000 | -53.6% | 9,561 | -49.8% | 0.00% | -100.0% |
| Q2 2021 | $110,000 | – | 19,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |